# OnCo record da-novo (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/da-novo/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "da-novo" ;
  schema:name "Novo Nordisk"@en ;
  schema:description "Novo Nordisk markets GLP-1 medicines for other indications and is testing semaglutide in Alzheimer’s EVOKE trials."@en ;
  schema:url <https://onco.cc/companies/da-novo/>, <https://www.novonordisk.com/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://www.novonordisk.com/> ;
  onco:tag "dementia-atlas" ;
  schema:addressCountry "DK" ;
  onco:drugs <https://onco.cc/drugs/da-semaglutide-evoke/> ;
  onco:trials <https://onco.cc/trials/da-trial-evoke/> .